Protocol Ledger

NCT04684238 · Phase III · COMPLETED

Effect & Safety of Inhaled Isoflurane vs IV Midazolam for Sedation in Mechanically Ventilated Children 3-17 Years Old

Interventional Phase III clinical trial protocol NCT04684238 sponsored by Sedana Medical in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-01-14 Enrollment: 94 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04684238
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)94 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04684238
Protocol FieldVerified Registry Value
NCT IdentifierNCT04684238
Consolidated Lead SponsorSedana Medical
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment94 participants (ACTUAL)
Registered Start Date2021-01-14
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI